Back to PathoKing

T2DM module

Type 2 Diabetes

Understand type 2 diabetes as insulin resistance plus beta-cell failure, linking hyperglycaemia to vascular, renal, nerve, and treatment priorities.

foundation25 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

Why insulin action becomes insufficient

Type 2 diabetes usually reflects several pressures acting on insulin sensitivity and beta-cell reserve.

Visceral adiposity and insulin resistance

Typical setting: Central weight gain is strongly associated with type 2 diabetes risk.

Adipose inflammation and altered lipid handling impair insulin signalling in liver, muscle, and fat.

Genetic susceptibility

Typical setting: Family history and ethnicity influence risk.

Inherited differences affect beta-cell reserve, insulin secretion, and insulin sensitivity.

Low muscle glucose demand

Typical setting: Physical inactivity reduces one of the body's major routes for glucose disposal.

Skeletal muscle becomes less effective at clearing glucose after meals.

Ageing beta-cell reserve

Typical setting: Risk rises with age, although younger onset is increasingly common.

Beta cells may become less able to compensate for insulin resistance over time.

Medication and endocrine contributors

Typical setting: Glucocorticoids, atypical antipsychotics, Cushing syndrome, and other states can worsen glucose handling.

Counter-regulatory hormone effects increase hepatic glucose output and insulin resistance.

Mechanism chain

The mechanism chain

The disease is best understood as a mismatch between insulin demand and beta-cell supply.

1

Insulin resistance rises

Muscle takes up less glucose, the liver continues producing glucose despite insulin, and adipose tissue releases more fatty acids.

2

Beta cells compensate

More insulin is secreted to hold glucose down, so insulin levels may be high before diabetes is diagnosed.

Checking account access...